Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
This randomized clinical trial assesses the efficacy and adverse events of baricitinib combined with narrowband UV-B in adults with severe, active, nonsegmental vitiligo.
This randomized clinical trial assesses the efficacy and adverse events of baricitinib combined with narrowband UV-B in adults with severe, active, nonsegmental vitiligo.
This nonrandomized controlled trial evaluates the association of patient-reported outcome–based remote symptom monitoring with health care utilization among patients with cancer.
This randomized trial assesses whether amiloride is noninferior to spironolactone in reducing home-measured systolic blood pressure among patients with resistant hypertension.
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with…
This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Recludix Pharma unveils a groundbreaking BTK SH2 inhibitor, showcasing superior selectivity and efficacy for chronic spontaneous urticaria treatment at SID 2025.
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.